FDA Inspection
Ascension Saint John Medical CenterAscension Saint John Medical Center – FDA Inspection, Dec 1, 2017
Record Details
This FDA Inspection record concerns Ascension Saint John Medical Center, with an inspection on December 1, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 86c80269-762e-4d87-a41a-8aaea0b5c6ad
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1034393
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 600.14(c)When to report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ascension Saint John Medical Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | VAI | Dallas District Office | Blood and Blood Products |
| July 19, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 11, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 4, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 14, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Ascension Saint John Medical Center
- FDA Inspection 1269887 - 2025-05-09
- FDA Inspection 1178182 - 2022-07-19
- FDA Inspection 964421 - 2016-03-11
- FDA Inspection 868330 - 2014-03-04
- FDA Inspection 767466 - 2012-02-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.